Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Novamind Inc.
NVMDF
Healthcare
Biotechnology
Novamind is a leading mental health company enabling safe access to psychedelic medicine through a network of clinics, retreats, and clinical research sites. Novamind provides ketamine-assisted psychotherapy and other novel treatments through its network of Cedar Psychiatry clinics and operates Cedar Clinical Research, a contract research organization specialized in clinical trials and evidence...
-based research for psychedelic medicine.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (OTCQB:NVMDF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
Next
(3)
•••
CDOKing
X
View Profile
View Bullboard History
Post by
CDOKing
on Mar 29, 2022 12:34pm
Bienstar Aqusition
https://www.benzinga.com/markets/cannabis/22/03/26352545/exclusive-bienstar-wellness-enters-brazilian-psychedelic-market-will-acquire-ibogaine-co#.YkMq-ClXY6E.twitter
(3)
•••
CDOKing
X
View Profile
View Bullboard History
Post by
CDOKing
on Mar 22, 2022 9:51am
Updated deck here, March 2022
https://docsend.com/view/mv76ri44cffrw9kd
Q Precious & Battery Metals to Drill Initial 1000 metres at La Corne and McKenzie East Gold Projects, Quebec
posted Apr 23, 2024 9:00am by
Q Precious & Battery Metals Corp
-
|
The Company is planning for an initial 1,000 metres of diamond drilling scheduled for mid- June 2024, with VMS targets on the La Corne South project at proposed depths ranging from 50 to 300 metres below surface as modelled by the EM survey and noted in historic drilling. TMC Geophysique completed deep-penetrating Pulse-EM -Time Domain Electromagnetic (TDEM) surveying on the claims that targeted ...read more
(328)
•••
Golddetector
X
View Profile
View Bullboard History
Comment by
Golddetector
on Feb 08, 2022 8:48am
RE:Bought 5k at 25c
I paid 30c and 50c for my shares. I might average down if it revisit the 25c again. Gl
(18)
•••
Pipess
X
View Profile
View Bullboard History
Post by
Pipess
on Feb 07, 2022 4:43pm
Bought 5k at 25c
GLTa <3
(9)
•••
JocetooBad
X
View Profile
View Bullboard History
Comment by
JocetooBad
on Feb 02, 2022 10:15am
RE:Added 10k at 30c today
Thanks for posting Golddetector. I'm also buying these days, since the fundamentals of the business that NM is standing up seem sound enough, with increasing demand, a solid brand, and modern
...more
(328)
•••
Golddetector
X
View Profile
View Bullboard History
Post by
Golddetector
on Feb 01, 2022 1:57pm
Added 10k at 30c today
Still believe in the fundamentals here. I think I'm getting a deal below pp and insiders. Long hold for me good luck longs
(328)
•••
Golddetector
X
View Profile
View Bullboard History
Post by
Golddetector
on Jan 27, 2022 8:14pm
Today’s sell off 😳
Wtf just after pp at 40c it is already 31. What happened here.
(9)
•••
JocetooBad
X
View Profile
View Bullboard History
Post by
JocetooBad
on Jan 24, 2022 11:11am
Frustrated that they finance way below market price
I don't understand why NM is just killing it's own share price with a private placement 20-25% below recent market price. WTH?! This is frustrating for early believers like me. Anyway
...more
(9)
•••
JocetooBad
X
View Profile
View Bullboard History
Post by
JocetooBad
on Dec 06, 2021 3:01pm
Novamind opens another specialized clinic - sticking to plan
Not sure why the stock keeps on dropping every time good news are announced... The company is on track with its plan and allocated funds for it properly. https://stockhouse.com/news/press-releases
...more
(9)
•••
JocetooBad
X
View Profile
View Bullboard History
Comment by
JocetooBad
on Dec 02, 2021 11:23am
RE:🎥📰Anthony Durkacz on Building a Turnaround at FSD Pharma📣
Wrong board - What do you have to say about Novamind?
(2)
•••
JayDestura
X
View Profile
View Bullboard History
Post by
JayDestura
on Nov 18, 2021 9:22pm
🎥📰Anthony Durkacz on Building a Turnaround at FSD Pharma📣
(2)
•••
JayDestura
X
View Profile
View Bullboard History
Post by
JayDestura
on Nov 17, 2021 10:13am
🎉📣FSD Pharma's Research and Clinical Advisory Board📢
Dr. Eleanor N. Fish, a world-renowned immunologist and cytokine expert, has been appointed to FSD Pharma's Research and Clinical Advisory Board. FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA
...more
(9)
•••
JocetooBad
X
View Profile
View Bullboard History
Post by
JocetooBad
on Nov 12, 2021 11:59am
No reason for this stock plunging in the 0.60-0.70 range
If we look at the latest news, they're all about expansion to meet demand, new contracts, and sound strategic investment decisions. The stop trade was only due to a hiccup in getting numbers
...more
(2)
•••
JayDestura
X
View Profile
View Bullboard History
Post by
JayDestura
on Nov 10, 2021 2:27am
📣FSD Pharma:Agreement Signed With Covar Pharmaceuticals📢📣
(2)
•••
JayDestura
X
View Profile
View Bullboard History
Post by
JayDestura
on Oct 30, 2021 10:39am
📢📣FSD Pharma forms agreement with Covar Pharmaceuticals 📢
Prev
1
2
3
4
5
6
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study
Discover a Green Resources Stock Scoring Record Quarterly Growth
Stage Set for Creation of a Leading Intermediate Gold Producer